XML 45 R31.htm IDEA: XBRL DOCUMENT v3.20.2
Organization and Summary of Significant Accounting Policies - Additional Information (Detail)
9 Months Ended
Sep. 30, 2020
USD ($)
Segment
Sep. 30, 2019
USD ($)
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]    
Number of operating segment | Segment 1  
Cash, cash equivalents and marketable securities $ 177,200,000  
Principal amount including interest paid in kind $ 180,900,000  
Debt maturity date Dec. 31, 2023  
Inventory reserve $ 0 $ 0
Maximum    
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]    
Expected period of payment to be received 1 year  
HEPLISAV-B®    
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]    
Minimum age approved for vaccine prevention of infection caused 18 years